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Freezing of gait (FOG) is a common, disabling gait disturbance in Parkinson’s disease 
(PD) and other Parkinsonian syndromes. Freezing also occurs during non-gait move-
ments involving the upper limbs. The mechanisms underlying freezing are complex, 
likely involving motor, cognitive, and sensory systems that contribute to the episodes. 
Here, we reported a 60-year-old female with a 24-year history of parkinsonism who 
experienced significant FOG when ambulatory. Disease progression resulted in her 
permanent use of a powered wheelchair. While using the power chair, the patient expe-
riences apparent paroxysmal freezing in the hand and arm used to steer and propel the 
chair. These episodes, some lasting up to several minutes, occur only in circumstances 
(e.g., entering and leaving an elevator) that are similar to environments known to elicit 
and exacerbate FOG. Episodes are transient and can be volitionally interrupted by the 
patient but sometimes require external assistance. Therapeutic intervention for this type 
of potential freezing has yet to be determined. This case may provide insight into the 
complex nature of freezing behavior and suggests a need for new approaches to treating 
non-traditional freezing behavior.
Keywords: parkinson’s disease, hypokinesia, upper-limb freezing, freezing, akinesia
INtRoDUCtIoN
Freezing of gait (FOG) is a common and disabling motor symptom of Parkinson’s disease (PD) 
and other Parkinsonian conditions. FOG is defined as a “brief, episodic absence or marked reduc-
tion of forward progression of the feet despite the intention to walk” (1). Approximately half of 
people with PD will experience FOG as the disease progresses (2). While it is typically associated 
with greater disease duration and dose of levodopa medication, FOG can affect some individuals 
earlier in the disease course (3). The health-related impact of FOG is concerning. FOG is associated 
with an increased risk of falling (4, 5), reduced quality of life (6), and cognitive impairment (7, 8). 
While pharmacologic and surgical treatment can alleviate freezing episodes in some patients, others 
continue to exhibit freezing behavior despite optimal treatment with these therapies (9, 10). These 
observations suggest that FOG may involve non-dopaminergic systems (3), but the causal pathways 
remain poorly understood.
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While freezing predominantly affects walking and stepping, 
recent work showed that freezing can affect non-gait motor 
systems as well (11). These data indicate that similar freezing 
can occur during upper-limb and finger movements (12–14), 
as well as during speech (15). While gait and non-gait freezing 
do not necessarily co-occur, these data suggest that some com-
mon mechanism underlies motor arrests in PD. As such, in the 
remainder of this case report, we will use the term “freezing” to 
include both gait and non-gait phenomena.
Various hypotheses describing potential mechanisms of freez-
ing have been proposed, including impaired automaticity (16), 
perceptual impairments (17), and cognitive-motor decoupling 
(18), and this remains an active area of research. Furthermore, 
non-dopaminergic systems such as serotonergic neurons in the 
raphe nucleus and cholinergic neurons in the pedunculopontine 
nucleus may also play a role (3). Thus, freezing likely involves 
a widespread network of various brain regions. In this case 
report, we describe a patient with dopa-responsive parkinsonism 
who experienced gait freezing when ambulatory and currently 
experiences apparent freezing only when operating her powered 
wheelchair in situations that often elicit gait freezing. The purpose 
of this case is to present a novel task-specific case of potential 
freezing and to summarize and expand on the potential neuro-
logical mechanisms of freezing.
Case RepoRt
The patient is a 60-year-old woman with a 24-year history of 
parkinsonism currently residing in an assisted living facility. She 
initially presented to our movement disorder clinic in 1996 with a 
4-year history of gradually progressive lower extremity pain and 
spasms, and blepharospasm following constipation and urinary 
urge. Baclofen and botulinum toxin targeting ocular muscles 
provided modest benefit for spasms. The differential remained 
broad and initial workup included normal brain magnetic 
resonance imaging (MRI), cervical, thoracic, and lumbar spine 
MRI, cerebrospinal fluid studies (cell count, protein, glucose, 
oligoclonal bands, Lyme titers), complete blood cell count, com-
prehensive metabolic panel, thyroid-stimulating hormone level, 
triiodothyronine (T3) levels, free thyroxine (T4) levels, serum 
immunofixation, ceruloplasmin, B12, Venereal Disease Research 
Laboratory, erythrocyte sedimentation rate, extractable nuclear 
antigen, antinuclear antibody (slightly elevated, but rheumatology 
follow-up revealed no association with clinical syndrome), vita-
min E, human immunodeficiency virus, human T-cell lympho-
tropic virus, very long chain fatty acids, electromyography/nerve 
conduction studies, serum and urine amino acids, conjunctival 
biopsy for lipofuscinosis, urine samples for arylsulfatase A, nega-
tive gene testing for spinocerebellar ataxia-type 3, and Huntington 
disease.
Over the next 2 years, she displayed progressive asymmetric 
(left more than right) leg and arm dystonia with concomitant 
development of asymmetric leg then arm rest tremor, rigidity, 
and impaired gait (asymmetric foot dragging) and balance. PD 
was diagnosed in 1998 following exquisite improvement of rest 
tremor, rigidity, dystonia, gait, and blepharospasm with initiation 
of carbidopa/levodopa (Unified Parkinson’s Disease Rating 
Scale motor subsection (UPDRS III) score improved from 38 to 
15.5 with titration). Over the next several years, she developed 
motor fluctuations with painful OFF-state left arm/leg dystonia 
and peak-dose cervical dystonia (worse on the left). Trials with 
ropinerole provided initial relief of OFF-state dystonia, but in late 
2001, she developed dose-limiting peak-dose dyskinesia and was 
unable to tolerate ropinerole or trials with pergolide, pramipexole, 
tolcapone, or entacapone in addition to amantadine and levo-
dopa. Over the next 3 years, she experienced worsening gait (due 
in part to worsening left leg dystonia) with freezing that resulted 
in at least 2 falls per week by 2004. In 2006, on examination, 
gait impairment was characterized independent of dystonia by 
inability to lift her feet, particularly on the left side, resembling 
the akinetic subtype of FOG (19). At this time, FOG was severe 
enough that she used a wheelchair when outside of the home for 
safety.
In June 2006, she underwent successful implantation of bilat-
eral subthalamic nucleus deep brain stimulation after OFF/ON 
evaluation revealed improvement of the UPDRS III score from 
69 in the practically defined OFF state to 13.5 following ingestion 
of 600  mg levodopa. DBS resulted in markedly reduced rigid-
ity and tremor, and relieved pain secondary to left arm and leg 
dystonia which allowed reduction of levodopa dosing over 50% 
during the first year. After DBS, the patient’s gait and mobility 
improved substantially, and she did not regularly use her power 
scooter. Three years following DBS, she required dose titrations 
and again developed motor fluctuations with worsening rest 
tremor, dystonia, and FOG. By July of 2009, she was still able to 
walk, but again preferred to use a power chair due to fear of falls 
in the context of worsening FOG. She was bound to her power 
chair in 2012 due to progression of gait instability and FOG with 
increased motor fluctuations.
In April 2015, the patient first reported intermittent right 
hand freezing while controlling her power wheelchair in specific 
situations. Three months later, this apparent freezing of the 
upper extremity began to interfere substantially with her ability 
to propel her power wheelchair, particularly when entering an 
elevator or passing through doorways. The apparent freezing 
was mostly in her fingers, which controlled the movement of 
her chair. During episodes, the patient does not display dystonic 
posturing of the wrist or hand typical of her OFF-period dystonia, 
or as an overflow phenomenon. As reported in May of 2016, the 
navigation-related upper-limb freezing episodes occur a few 
times per day. The suspected freezes observed in the clinic usually 
lasted just a few seconds, but the patient reports episodes may last 
for as long as 1–10 min. The patient is typically able to break the 
motor arrests using her other hand (left) to release fingers of the 
right hand from the steering knob. In cases where the episodes 
last several minutes, staff members at her living facility intervene 
to help break the motor arrest. These apparent freezing episodes 
occur when moving the wheelchair both forward and backward. 
Entering and exiting elevators are the most common triggers, 
though navigating around the dining room in the presence of 
other residents who make her feel nervous occasionally triggers 
these episodes of potential freezing. The patient reports that these 
taBle 1 | Current medications.
Medication total daily 
dose (mg)
Comments
Parkinsonism Sinemet (carbidopa–levodopa) 150/600
Sinemet (carbidopa–levodopa) 25/100 1 tablet 4×/day, 
as needed
Sinemet (carbidopa–levodopa) 50/200 1 tablet at 
bedtime
Psychiatric Cymbalta (duloxetine) 90
Dextroamphetamine Sulfate 40
Mirtazapine 30
Pain Acetaminophen 325 As needed
Baclofen 50 10 mg 3×/day, 
20 mg at bedtime
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navigation-related upper-limb freezing episodes are similar to 
gait freezing she experienced previously and are accompanied 
by similar sensations and feelings of panic without other panic 
attack features. These episodes can occur either at peak dose or in 
the off state, but are more frequent and last longer in the off state. 
Because the patient is no longer ambulatory, we cannot determine 
if she still experiences gait freezing. The patient does not report 
this potential upper-limb freezing during any other upper-limb 
tasks nor does the apparent upper-limb freezing occur during 
wheelchair steering in other circumstances, such as navigating 
a wide open space. This is consistent with observations in our 
clinic.
On examination, she had saccadic intrusions on smooth 
pursuit, but no additional extraocular movement abnormalities. 
Finger tapping, hand movement, and leg agility were slow with 
diminished amplitude in the OFF more than ON state, but move-
ment always remained visible, except at the moments described 
when operating her chair. Bradykinesia remained fairly constant 
in the OFF state, whereas the apparent freezing phenomenon was 
transient, most often lasting about 5–15 s (though occasionally 
longer). There was no increase or change in dystonic postur-
ing when she attempted to initiate hand movements to control 
the wheelchair, and she lacked subjective pain that frequently 
accompanied OFF-period dystonia. She was otherwise able to 
accurately maneuver the wheelchair throughout most of the day, 
despite obvious and painful hand dystonia. She denied subjective 
concerns of not knowing how to make the desired movement 
during freezing episodes, and she lacked constructional or 
ideomotor apraxia on formal testing. Freezing episodes did not 
depend on whether observers were present or on any apparent 
psychological rewards.
She has an extensive psychiatric history including the follow-
ing symptoms: major depression, hallucinations, and suicidal 
ideation. Psychiatric treatments have included thiothixene, 
quetiapine, and electroconvulsive therapy with good benefit. 
Antipsychotics were last prescribed 10–15 years prior to her first 
visit at our center (except for 1–3 nightly doses of quetiapine 
12.5  mg in 2014). Depression occurring concomitantly with 
parkinsonism was treated intermittently with nortriptyline, 
mirtazapine, paroxetine, nefazodone, and duloxetine. The patient 
has a family history of paranoid schizophrenia (brother) and 
alcoholism. At present, she is cognitively normal (Mini-Mental 
Status Exam score of 27, Montreal Cognitive Assessment score of 
28) and has no evidence of changes in memory.
The patient’s current medications as of October 2016 are 
summarized in Table  1, categorized as “parkinsonism,” “psy-
chiatric,” and “pain.” Her prescribed levodopa equivalent daily 
dose is 650 mg, and she currently takes only levodopa (i.e., no 
agonists or MAOB inhibitors). Frequent revision of medication 
schedules, particularly following DBS, was a major part of her 
management as the patient experienced constant debilitating 
pain, frequent on- and off-period dystonia, and occasional 
hallucinations. Motor benefit from levodopa (taken every 3  h 
from 6 a.m. to 6 p.m. and CR at 9 p.m.) appeared in 30  min, 
and lasted until 30–45 min prior to her next dose. The UPDRS 
was administered 53  min after a regular dose of carbidopa/
levodopa during her October 2016 visit. The summary scores 
are as follows: Part I: 3/16, Part II: 25/52, Part III: 64.5/108, and 
Part IV: 4/23. For subscale III (motor), the patient has severe 
bradykinesia and hypokinesia, hypophonia, and cannot rise 
from her motorized chair without assistance. DBS settings were 
last adjusted in January of 2015. Neither medication nor DBS 
therapies currently provide sufficient relief for this patient’s 
apparent task-specific upper-limb freezing during navigation, 
though she reports worse and more frequent episodes during 
off-medication periods.
DIsCUssIoN
Freezing is a complex and poorly understood feature of PD. The 
pathophysiological and behavioral mechanisms associated with 
freezing likely involve motor, cognitive, and sensory factors (20). 
How these factors interact is still not fully understood and, as a 
result, the current array of treatment approaches for freezing do 
not provide sufficient long-term benefit (21). In this report, we 
describe a novel case of a patient who previously experienced gait 
freezing, and while now non-ambulatory, experiences episodes 
in the upper limb that appear to be freezes when navigating 
her wheelchair in specific situations that also commonly elicit 
FOG. The circumstances and sensations during these episodes as 
reported by the patient are similar to those experienced during 
previous gait freezing. To our knowledge, this is one of the first 
reports of apparent freezing of another part of the body during 
a navigation-related task (i.e., steering a wheelchair). Systematic 
studies of upper-limb freezing manipulated the spatiotemporal 
components of the task to induce freezing (12–14); however, it 
was not clear if these participants also experienced upper-limb 
freezing during other tasks or in specific environments (such as 
when passing through narrow spaces).
While the motor demands differ between walking and 
navigating a wheelchair, sensory aspects such as optic flow 
are similar. One current hypothesis is that freezing is due to 
perceptual impairments related to visuomotor integration 
of one’s body within the environment (17). Evidence for this 
comes from patient reports as well as experiments examining 
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how people with PD walk through spaces with varying widths, 
such as doorways (22, 23). The patient reported that her freezing 
was worse when entering/exiting elevators and when finding a 
seat in the dining hall. Both situations challenge spatial judg-
ment, and navigating in the dining hall was also emotionally 
taxing for this particular patient. In addition, the cognitive and 
emotional demands associated with these scenarios are similar 
in both walking and using a wheelchair. Complex tasks can 
exacerbate freezing (24), and fear related to prior freezing events 
may increase anxiety and also contribute to freezing (25). This 
patient has a history of mood disorder that may contribute to 
emotion-related freezing triggers. Since cognitive-motor over-
load is also a plausible mechanism for freezing behavior (18), 
cognitive interference may play a role in this case as it does in 
other types of freezing. Though we saw no evidence of cogni-
tive impairment in this individual, increasing cognitive load 
has been shown to trigger freezing episodes in people with PD 
who experience freezing, regardless of cognitive status (3, 26). 
As a result, cognitive-motor interference may contribute to this 
phenomenon. Overall, these hypotheses suggest a more general 
mechanism that could apply to both FOG and upper-limb freez-
ing during navigation, even though these two tasks have very 
different motor demands.
We cannot rule out other explanations for the phenomenon 
described in this case. Dystonia is a common side effect of dopa-
minergic treatment, usually occurring in the off-period (27). 
The patient experienced previous dystonia in the lower limbs 
during both on- and off-medication periods. The interruption 
in her intended upper-limb movements could also potentially 
be attributed to a form of dystonia. However, this is unlikely 
because the patient’s previous dystonia was generalized and not 
associated with certain tasks or situations, whereas the current 
apparent freezing occurs only in the upper limb involved in 
wheelchair navigation and only during specific situations. More 
directly, dystonic posturing and pain were absent during the 
episodes, and finger torsion or deviation was not observed upon 
examination. Further, the patient did not report focal muscle 
tension during these episodes of suspected freezing while using 
the wheelchair. Recordings of muscle activity during upper-limb 
freezing episodes were not able to be collected for this patient. 
However, in future cases of suspected task-specific upper-limb 
freezing, this may help distinguish between dystonia, which is 
characterized by sustained agonist/antagonist co-contraction 
(28), and freezing, which is typically accompanied by inappro-
priate timing of agonist/antagonist muscle pairs (3). General but 
severe bradykinesia could feasibly contribute to the interruption 
of her upper-limb movements as well. On the UPDRS III, the 
patient scored a 4 on body bradykinesia and hypokineisa, and 
a 3 or 4 on finger tapping, hand movements, and leg agility. 
However, the duration of the episodes are too long to be purely 
bradykinetic in nature, and the patient is able to volitionally 
break the motor arrests herself in most cases, similar to what is 
seen in FOG.
This phenomenon of apparent upper-limb freezing is also 
unique from typical episodes of lower limb or gait freezing. 
For example, the maximal duration of the episodes reported 
by the patient is atypically long compared to most reports of 
FOG. Most FOG episodes last less than 10  s and rarely last 
more than 30  s before movement is regained (19). However, 
episodes observed within the clinic were all within the typical 
reported range. The lack of arm trembling concurrent with the 
episode is also uncharacteristic of FOG. However, there are 
numerous reports of upper-limb freezing episodes described 
as a cessation of movement in one or more hand that are not 
accompanied by trembling (29–32). Further, striking similari-
ties between this phenomenon of apparent upper-limb freez-
ing and FOG include the identifiable environmental triggers 
(crowded spaces, passageways) and the ability to interrupt the 
episodes.
CoNClUsIoN
Overall, unique cases such as this highlight the need to consider 
freezing as a problem affecting the entire sensorimotor system 
and emphasize the need for clinicians and researchers to develop 
new treatments for non-gait freezing.
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